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Abstract
Background: The potential of next-generation sequencing (NGS) for hypothesis-free pathogen diagnosis from
(poly-)microbially contaminated, formalin-fixed, paraffin embedded tissue samples from patients with invasive
fungal infections and amebiasis was investigated. Samples from patients with chromoblastomycosis (n = 3),
coccidioidomycosis (n= 2), histoplasmosis (n = 4), histoplasmosis or cryptococcosis with poor histological discriminability
(n = 1), mucormycosis (n = 2), mycetoma (n= 3), rhinosporidiosis (n = 2), and invasive Entamoeba histolytica infections (n =
6) were analyzed by NGS (each one Illumina v3 run per sample). To discriminate contamination from putative infections
in NGS analysis, mean and standard deviation of the number of specific sequence fragments (paired reads) were
determined and compared in all samples examined for the pathogens in question.
Results: For matches between NGS results and histological diagnoses, a percentage of species-specific reads greater than
the 4th standard deviation above the mean value of all 23 assessed sample materials was required. Potentially
etiologically relevant pathogens could be identified by NGS in 5 out of 17 samples of patients with invasive
mycoses and in 1 out of 6 samples of patients with amebiasis.
Conclusions: The use of NGS for hypothesis-free pathogen diagnosis from contamination-prone formalin-
fixed, paraffin-embedded tissue requires further standardization.
Keywords: NGS, Next-generation sequencing, Hypothesis-free diagnosis of infection, Invasive fungal infections,
Invasive amebiasis, FFPE, formalin-fixed, paraffin-embedded samples, Molecular diagnostics, Tropical infectious
diseases, Metagenome
Background
Reliable results of microbiological diagnostic approaches,
in particular of cultural approaches, require suitable
pre-analytical conditions as a prerequisite [1]. The
intentional or unintentional inactivation of infectious
agents can complicate diagnostic procedures. This is the
case, for example, when the possibility of infection is not
taken into account during initial sampling, so that the
sample material is fixed for histopathological work-up in
4% buffered formalin for the purpose of preservation of
tissue structure and subsequently embedded in paraffin
in the pathology laboratory. If histology provides evi-
dence of an infectious cause for an inflammatory reac-
tion, cultural diagnostic approaches are no longer
possible because of inactivation of microorganisms by
formalin.
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The sensitivity of molecular diagnostic methods, for
example, of polymerase chain reaction (PCR), is signifi-
cantly reduced by formalin due to nucleic acid and pro-
tein cross-linking, deamination of cytosine to uracil,
strand breaks, and the difficulty of extracting DNA from
paraffin-embedded tissues [2–7]. If the microscopic de-
tection of pathogens proves inconclusive, the molecular
detection of pathogens from formalin-fixed sample ma-
terial is nevertheless the most promising approach if
fresh sample material cannot be obtained or can only be
obtained with a significant health risk for the patient [7].
The sensitivity of molecular pathogen detection from
formalin-fixed, paraffin-embedded (FFPE) tissue is influ-
enced by factors such as sample age and pathogen dens-
ity [7]. Best results can be expected for PCRs that
amplify very short fragments, since the formalin-induced
strand breaks, cross-linking of DNA strands, and pro-
tein–DNA cross-links prevent the amplification of larger
fragments. Such cross-linking events are—stochastic-
ally—expected about every 1000 base pairs and reduce
the reliability of PCRs with longer amplicons. This is es-
pecially true if samples inherently include only small
quantities of pathogen DNA [7].
A limitation of targeted PCR diagnostics is the fact
that primer-based nucleic acid amplification detects nu-
cleic acids of defined pathogens or groups of pathogens
only. If symptoms of the patient are nonspecific and can
be induced by a variety of potential pathogens, rational
selection of applicable PCR panels that are both compre-
hensive and economical can represent a differential diag-
nostic challenge [8].
Pan-bacterial or pan-fungal ribosomal RNA gene PCRs
with subsequent Sanger sequencing [9] for the
sequence-based identification of bacteria and fungi in the
sample material [10] are potential alternatives to genus-
or species-specific PCR. These procedures are poorly stan-
dardized and therefore—especially in case of a negative re-
sult—doubtful in their diagnostic reliability [10], although
they can provide valuable information in case of a positive
result. There is complementary diagnostic value of this
method mainly for sterile sample materials obtained from
primary sterile compartments; for example, bioptic mater-
ial of endocarditis patients [11]. In mixed cultures or sam-
ples with poly-microbial contamination, mixed sequences
occur in Sanger sequencing that do not allow reliable
pathogen identification [12]. However, such microbial
contamination has to be regularly expected in
formalin-fixed, paraffin-embedded sample material due to
nonsterile storage of the paraffin blocks or contamination
in the paraffin wax itself [13]. Consequently, the diagnos-
tic value of such procedures is limited for FFPE materials.
The diagnostic application of NGS (next-generation
sequencing) from primary material is a potential alterna-
tive. Hypothesis-free NGS has been used to successfully
attribute etiologically unclear infection events to specific
pathogens [14]. However, NGS is also suitable for the
assessment of primary nonsterile sample materials. The
assignment of etiological relevance with respect to the
existing clinical symptoms can be based upon the rela-
tive frequency of pathogen-specific nucleic acid se-
quences [15] or on the pathogenicity of molecularly
proven microorganisms. An example is the diagnosis of
ornithosis by NGS-based demonstration of C. psittaci
DNA in respiratory secretions of patients with severe re-
spiratory infection of unknown origin [16].
The application of NGS with FFPE sample materials in
general [17] and the purpose of pathogen detection and
typing from such materials in particular [18] are the sub-
jects of ongoing evaluation studies. The present study
deals with NGS-based detection of invasive, mostly trop-
ical, mycoses and invasive amebiasis from histological
specimens. Matching between NGS and specific PCR for
E. histolytica or panfungal PCR with subsequent Sanger
sequencing as well as potential additional information
on relevant etiologic pathogens provided by NGS are
assessed.
The hypothesis of the study is that NGS may be more
suitable for the hypothesis-free genomic detection of
rare invasive infections in potentially poly-microbially
contaminated, formalin-fixed, paraffin-embedded tissue
samples than PCR with subsequent Sanger sequencing.
The advantage of NGS is its suitability for parallel se-
quencing of virtually all DNA sequences within a bio-
logical sample, depending only on the depth of
sequencing. If, in contrast, PCR primers with specificity
for multiple pathogens, such as pan-fungal primers, lead
to amplification of sequences of different pathogens
within the same sample, overlays of different sequences
can lead to non-interpretable results in Sanger
sequencing.
Results
Results of the NGS analyses
The number of evaluable sequence fragments (reads) per
sample averaged 9,799,803 ± 6,662,643 (standard devi-
ation) (lowest number 2,717,953 reads; highest number
29,225,435 reads) in the NGS examination. Among these
reads, an average of 26% ± 19% (lowest percentage 1%;
highest percentage 59%) could not be identified by the
Kraken software.
No significant Spearman rank correlation between
sample age and number of detected reads could be iden-
tified with Spearman r = 0.2962 (corrected for ties), a
95% confidence interval of − 0.1449 to 0.6391, and a
non-significant two-tailed P = 0.1699 (calculated using
the software GraphPad InStat, version 3.06, 32 bit for
Windows, GraphPad Software Inc., San Diego, CA,
USA).
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The proportion of sequences of eukaryotic organisms
in the sample averaged 39.7% ± 36.7%. The largest share
consisted of human reads at 37.6% ± 37.2%. The propor-
tion of fungal sequences was a mere 0.12% ± 0.16%. Bac-
terial sequences constituted an average of 23.9% ± 22.0%,
viral sequences an average of 10.5% ± 7.2%. The identi-
fied sequences covered a wide spectrum of different spe-
cies without clear relation to the histologically defined
invasive infections. Among the bacterial sequences,
Pseudomonas spp.-specific reads constituted 0.6% ± 0.6%
of all reads, and Staphylococcus spp.-specific reads
0.01% ± 0.02% of all reads. Although some of the pa-
tients with invasive fungal infections had suffered from
AIDS (personal communication with the Department of
Pathology of the Bernhard Nocht Institute for Tropical
Medicine Hamburg, which initially provided the sam-
ples), proviral DNA of HIV was undetectable in any of
the samples.
The distribution of detectable reads is visualized in
Table 1.
Focusing on the proven fungal sequences in the sam-
ples of the patients with invasive fungal infections,
etiologically relevant pathogens, i.e. Histoplasma capsu-
latum, Madurella mycetomatis, and Fusarium pseudo-
graminearum, matching the histological diagnosis were
detected in 3 out of 17 samples among the three most
frequently detected fungal species. Among these, there
were two cases of histoplasmosis and mycetoma that
were also confirmed by pan-fungal PCR [13] (see below).
Specifically, Histoplasma capsulatum sequences consti-
tuted the most frequent fungal reads in the histoplasmo-
sis sample. In detail, the corresponding reads were 0.02%
of total reads in the sample and 34% of fungal reads.
Madurella mycetomatis–specific sequences amounted to
0.001% of total reads in the respective sample and 4% of
fungal reads, corresponding to position 3 of the most
frequently detected fungal sequences in the mycetoma
sample. In another mycetoma sample, a Fusarium spe-
cies, here Fusarium pseudograminearum, was on pos-
ition 2 of the most frequently detected fungi with 0.02%
of total reads in the sample and 16% of fungal reads. In
all other samples studied, spores of fungi from the envir-
onment were on positions 1 to 3 of the most frequently
detectable fungal reads. The frequently detected
Table 1 Detectable reads per sample and distribution by kingdom








Fungi Bacteria Viruses Archaea
1 Chromoblastomycosis 3,937,419 1,147,985 2,789,434 21,600 2046 478,980 645,351 8
2 Mucormycosis 9,624,603 3,993,184 5,631,419 1,826,409 4829 1,103,678 1,058,228 40
3 Histoplasmosis 10,377,343 9,642,335 735,008 8,649,198 1015 138,392 853,722 8
4 Mucormycosis 2,717,953 1,219,660 1,498,293 237,965 850 261,919 718,923 3
5 Histoplasmosis or
cryptococcosis
6,697,156 2,829,244 3,867,912 841,420 3087 1,484,221 500,489 27
6 Chromoblastomycosis 6,986,916 5,321,271 1,665,645 416,898 995 3,399,811 1,503,362 205
7 Rhinosporidiosis 4,437,770 1,742,087 2,695,683 215,943 3209 826,178 696,741 16
8 Mycetoma 2,729,331 1,935,487 793,844 1,153,381 1661 125,046 655,398 1
9 Rhinosporidiosis 6,383,726 1,568,557 4,815,169 28,812 3579 906,363 629,763 40
10 Mycetoma 5,596,933 2,098,943 3,497,990 901,105 3678 627,175 566,972 13
11 Histoplasmosis 7,109,960 5,690,358 1,419,602 1,145,879 16,632 3,252,319 1,275,523 5
12 Histoplasmosis 3,083,524 1,148,615 1,934,909 205,871 6699 408,619 527,415 11
13 Chromoblastomycosis 12,529,855 6,557,056 5,972,799 4,427,985 8699 1,055,351 1,064,979 42
14 Histoplasmosis 7,901,861 6,886,130 1015,731 5,895,735 2171 413,407 574,811 6
15 Coccidioidomycosis 7,570,025 2,732,014 4,838,011 359,079 9784 1,757,949 605,165 37
16 Coccidioidomycosis 8,791,653 7,216,906 1,574,747 4,307,983 1696 2,422,677 484,421 129
17 Mycetoma 9,178,967 7,682,742 1,496,225 6,872,406 1116 237,152 572,064 4
18 Invasive amebiasis 16,947,754 15,543,806 1,403,948 583,362 561 13,508,300 1,447,733 3850
19 Invasive amebiasis 7,267,378 6,313,385 953,993 6,255,013 1446 45,602 11,324 0
20 Invasive amebiasis 22,840,836 22,215,617 625,219 21,555,613 2401 151,650 505,953 0
21 Invasive amebiasis 24,171,093 22,848,176 1,322,917 22,100,882 6631 193,348 547,309 6
22 Invasive amebiasis 29,225,435 28,785,110 440,325 28,194,606 1284 63,325 525,890 5
23 Invasive amebiasis 15,262,467 12,996,958 2,265,509 12,256,665 5047 138,208 597,018 20
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environmental fungi comprised Auricularia delicata, Bo-
trytis cinerea, Coniosporium apollinis, Debaryomyces
hansenii var. Hansenii, Eutypa lata, Gaeumannomyces
graminis, Malassezia globosa, Marssonina brunnea,
Meyerozyma guilliermondii, Neofusicoccum parvum,
Parastagonospora nodorum, Penicillium rubens, Pestalo-
tiopsis fici, Pseudozyma hubeiensis, Sordaria macrospora,
Thielavia terrestris, Trametes versicolor, Verticillium
alfalfae, and Wallemia ichthyophaga. Facultatively
pathogenic species like Aspergillus flavus, Candida
orthopsilosis, Candida parapsilosis, and Fusarium pseu-
dograminearum without relation to the histologically di-
agnosed disease were also among the three most
frequently detected species.
The abundance or absence of sequences of fungi with
potential etiological relevance in line with the histo-
logical diagnoses of the fungal sample collection was
also studied in all samples (see “Materials and Methods”
for the selection of the assessed fungi). The species de-
tected, the average percentage of the corresponding
reads in all samples (± 1 standard deviation), and the
average percentage of respective reads as a proportion of
the fungal reads (± 1 standard deviation) are shown in
Table 2. If genera listed in the “Materials and Methods”
section are not represented in Table 2, no corresponding
detectable reads were found in any of the assessed
samples.
Since mycetoma can also be caused by bacteria, the
same approach was adopted for relevant bacterial spe-
cies. This is illustrated in Table 3.
The results for Entamoeba spp., E. histolytica and E.
dispar, are given in Table 4.
In a diagnostic total genomic survey such as occurs in
NGS analysis, relevant pathogens must be distinguished
from random contamination events in the context of
sample preparation. It was therefore investigated how
the proportions of pathogen-specific reads in cases of
etiologic relevance differ from accidental contamination
events. For this, it was determined for which samples
the detected percentage of reads per pathogenic species
exceeded the 1st, 2nd, 3rd, or 4th standard deviation
from the mean of all samples and whether the results
were consistent with the histological diagnoses. The re-
sults of the screenings for pathogenic fungi in the pa-
tients with fungal infections are shown with the focus on
the percentage of the total number of reads in Table 5
and on the percentage of fungus-specific reads in Table
6. Table 7 provides a corresponding overview for the
amebas.
For the assessment based on the total number of
reads, detection of potentially relevant fungal species
above the 4th standard deviation succeeded in 5 sam-
ples, above the 3rd standard deviation in 1 sample,
above the 2nd standard deviation in 4 samples, and in 8
samples pathogens were detected above the 1st standard
deviation above the mean. No such increased quantities
were detected for 5 samples. In all of the 5 samples with
fungus detection above the 4th standard deviation, the
findings agreed with the histological result. The single
detection above the 3rd standard deviation did not agree
with the histological result. For the 4 samples with posi-
tive results above the 2nd standard deviation, there was
a match in 1 case and a mismatch in the 3 other cases.
For the 8 samples with fungal detection above the 1st
standard deviation, matching was found in 1 case and
mismatching in the other 7 cases (Table 5).
Of note, fungal sequences were also found in the 6 biop-
sies from the gut of the patients with invasive amebiasis.
Compared with the total numbers of reads, detections
above the 4th standard deviation occurred in 16 instances
(0.02% Pythium ultimum, 0.000009% Exophiala pisciphila,
0.0001% Sporothrix schenckii, 0.00002% Mortierella verti-
cillata, 0.00003% Cryptococcus stepposus, 0.002% Seto-
sphaeria turcica, 0.002% Leptosphaeria maculans,
0.00002% Fusarium solani, 0.0001% Cryptococcus victor-
iae, 0.00002% Cryptococcus tronadorensis, 0.0002% Cryp-
tococcus gattii, 0.0002% Cladosporium cladosporioides,
0.0003% Capronia coronata, 0.0009% Bipolaris zeicola,
0.001% Bipolaris sorokiniana, 0.001% Bipolaris oryzae).
Detections above the 3rd standard deviation succeeded in
4 instances (0.009% Aspergillus spp., 0.0003% Cladophia-
lophora carrionii, 0.0008% Paracoccidioides brasiliensis,
0.00002% Acremonium chrysogenum), above the 2nd
standard deviation in 10 instances (0.0006% Capronia epi-
myces, 0.0004% Chaetomium thermophilum var. Thermo-
philum, 0.0002% Cryptococcus neoformans, 0.0002%
Exophiala dermatitidis, 0.0005% Paracoccidioides sp. ‘lut-
zii’, 0.0002% Cladophialophora psammophila, 0.000005%
Exophiala pisciphila, 0.0004% Coccidioides immitis,
0.0004% Coccidioides posadasii, 0.00001% Fusarium
solani), and above the 1st standard deviation in 11 in-
stances (0.000008 and 0.00001% Aspergillus spp., respect-
ively, 0.00008% Cladosporium cladosporioides, 0.0003%
Coccidioides immitis, 0.0003% Coccidioides posadasii,
0.0002% (in three instances) Cyphellophora europaea,
0.0001% Fusarium graminearum, 0.0007% Leptosphaeria
maculans, 0.0004% Paracoccidioides sp. ‘lutzii’).
On a comparison with the fungal reads only, there
were 5 detections above the 4th standard deviation, 1
detection above the 3rd standard deviation, 4 detections
above the 2nd standard deviation, and 6 detections
above the 1st standard deviation. Although all detections
above the 4th standard deviation and 2 out of 4 detec-
tions above the 2nd standard deviation matched the
histological findings, no other results matched the histo-
logical diagnoses (Table 6).
Again, there were fungal sequences in the 6 biopsies
from the gut of the patients with invasive amebiasis.
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Compared with the total numbers of fungal reads only,
detections above the 4th standard deviation occurred in 8
instances (0.2% Sporothrix schenckii, 0.03% Mortierella
verticillata, 0.03% Exophiala pisciphila, 0.1% Cryptococcus
victoriae, 0.02% Cryptococcus tronadorensis, 0.06% Crypto-
coccus stepposus, 0.9% Coccidioides posadasii, 0.9% Bipo-
laris sorokiniana), above the 3rd standard deviation in 14
instances (8% Aspergillus spp., 0.1% Acremonium chryso-
genum, 0.9% Bipolaris oryzae, 0.8% Bipolaris zeicola, 0.3%
Capronia coronata, 0.4% Cladosporium cladosporioides,
1% Coccidioides immitis, 0.2% Cryptococcus gattii, 0.7%
Cyphellophora europaea, 0.3% Fusarium graminearum,
0.3% Fusarium solani, 2% Leptosphaeria maculans, 1%
Paracoccidioides sp. ‘lutzii’, 2% Setosphaeria turcica), above
Table 2 Detectable fungal species and their relative proportion of reads in the samples
Species Mean percentage of reads in the sample
(± 1 standard deviation)
Mean percentage of fungal reads in the sample
(± 1 standard deviation)
Aspergillus spp. 0.001967% ± 0.001822% 2.2087% ± 1.6228%
Acremonium chrysogenum 0.000002% ± 0.000005% 0.0081% ± 0.0260%
Bipolaris oryzae 0.000110% ± 0.000218% 0.1420% ± 0.2276%
Bipolaris sorokiniana 0.000090% ± 0.000210% 0.0891% ± 0.1922%
Bipolaris zeicola 0.000085% ± 0.000187% 0.1272% ± 0.2026%
Capronia coronata 0.000046% ± 0.000063% 0.0586% ± 0.0775%
Capronia epimyces 0.000177% ± 0.000162% 0.2813% ± 0.3244%
Chaetomium globosum 0.000197% ± 0.000137% 0.2739% ± 0.2444%
Chaetomium thermophilum var. Thermophilum 0.000092% ± 0.000112% 0.1204% ± 0.1443%
Cladophialophora carrionii 0.000058% ± 0.000068% 0.1014% ± 0.1472%
Cladophialophora psammophila 0.000060% ± 0.000064% 0.0989% ± 0.1323%
Cladophialophora yegresii 0.001570% ± 0.001623% 1.2943% ± 1.1669%
Cladosporium cladosporioides 0.000017% ± 0.000045% 0.0422% ± 0.0986%
Coccidioides immitis 0.000093% ± 0.000109% 0.1463% ± 0.2174%
Coccidioides posadasii 0.000094% ± 0.000133% 0.1209% ± 0.1931%
Cryptococcus carnescens 0.000000% ± 0.000002% 0.0004% ± 0.0021%
Cryptococcus gattii 0.000021% ± 0.000043% 0.0221% ± 0.0480%
Cryptococcus neoformans 0.000041% ± 0.000061% 0.0559% ± 0.0865%
Cryptococcus stepposus 0.000001% ± 0.000006% 0.0026% ± 0.0125%
Cryptococcus tronadorensis 0.000001% ± 0.000004% 0.0009% ± 0.0042%
Cryptococcus victoriae 0.000004% ± 0.000021% 0.0043% ± 0.0209%
Cyphellophora europaea 0.000076% ± 0.000111% 0.1233% ± 0.1819%
Exophiala dermatitidis 0.000033% ± 0.000057% 0.0422% ± 0.0670%
Exophiala pisciphila 0.000001% ± 0.000002% 0.0017% ± 0.0064%
Fusarium graminearum 0.000035% ± 0.000047% 0.0440% ± 0.0743%
Fusarium pseudograminearum 0.000978% ± 0.004153% 0.8826% ± 3.3271%
Fusarium solani 0.000001% ± 0.000005% 0.0022% ± 0.0074%
Histoplasma capsulatum 0.001019% ± 0.004143% 1.6474% ± 7.0562%
Leptosphaeria maculans 0.000243% ± 0.000419% 0.3583% ± 0.4897%
Madurella mycetomatis 0.000045% ± 0.000208% 0.1752% ± 0.8338%
Mortierella verticillata 0.000001% ± 0.000004% 0.0013% ± 0.0063%
Paracoccidioides brasiliensis 0.000156% ± 0.000189% 0.1896% ± 0.2083%
Paracoccidioides sp. ‘lutzii’ 0.000132% ± 0.000156% 0.2044% ± 0.2638%
Pythium ultimum 0.000871% ± 0.004170% not classified as a fungus
Rhizopus oryzae 0.000002% ± 0.000008% 0.0022% ± 0.0104%
Setosphaeria turcica 0.000240% ± 0.000425% 0.3191% ± 0.4822%
Sporothrix schenckii 0.000005% ± 0.000021% 0.0096% ± 0.0417%
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the 2nd standard deviation in 13 instances (0.8% Paracoc-
cidioides sp. ‘lutzii’, 0.7% (twice) Paracoccidioides brasilien-
sis, 0.2% Fusarium solani, 0.2% Fusarium graminearum,
0.2% Exophiala dermatitidis, 0.5% Cyphellophora euro-
paea, 0.3% Cryptococcus neoformans, 0.4% Cladophialo-
phora psammophila, 0.4% Cladophialophora carrionii, 1%
Capronia epimyces, 0.6% Bipolaris oryzae, 0.8% Acremo-
nium chrysogenum), and above the 1st standard deviation
in 30 instances (4% Aspergillus spp., 0.4% Bipolaris oryzae,
0.3% Bipolaris sorokiniana, 0.4 and 0.5% Bipolaris zeicola,
respectively, 0.2% (twice) Capronia coronata, 0.9% Capro-
nia epimyces, 0.4 and 0.3% (three times) Chaetomium
thermophilum var. Thermophilum, respectively, 0.3% Cla-
dophialophora carrionii, 0.3% (twice) Cladophialophora
psammophila, 0.1% Cryptococcus gattii, 0.2% (twice) Cryp-
tococcus neoformans, 0.4% Cyphellophora europaea,
0.009% Exophiala pisciphila, 1 and 0.9% Leptosphaeria
maculans, respectively, 0.4% (three times) Paracocci-
dioides brasiliensis, 0.5% Paracoccidioides sp. ‘lutzii’, 1%
(twice) and 0.9% Setosphaeria turcica, respectively).
The partial mismatch between the comparisons with
the whole of the reads and the comparisons with the
fungal reads only in the fungal samples is due to the
considerable differences in the proportions of assignable
reads as well as eukaryotic, bacterial, and viral reads (see
above). Matching of results above the fourth standard
deviation was found for all reads and fungal reads only;
only two other cases (samples 9 and 10) showed
matches, and those above only the first standard devi-
ation. There is striking concordance of the two positive
detections in pan-fungal PCRs, histology, and NGS
results (Tables 5 and 6). Even the species Madurella
mycetomatis, which accounted for only 4% of fungal
reads, was amplified preferentially in one of the
pan-fungal PCRs. Examples such as Histoplasma capsu-
latum in sample 14 and Madurella mycetomatis in sam-
ple 17 also show that a high percentage of specific reads
of a pathogen can give a hint on its potential etiologic
relevance. This did not apply, however, to all cases under
investigation (for example, samples 4, 5). In addition, the
percentage of reads of fungi from the environment was
quantitatively dominant in nearly all cases with the
exception of sample 14. Thus, no compelling association
between etiologic plausibility and quantitative propor-
tion of detected reads was confirmed.
Only results above the first and second standard devi-
ation above the mean value were observed for reads of
relevant actinomycetoma-associated bacteria (Nocardia
and Streptomyces). Based on the totality of reads, Nocar-
dia brasiliensis (0.06%, histologically rhinosporidiosis)
was measured once above the 2nd standard deviation.
Above the 1st standard deviation, Nocardia brasiliensis
was found in 7 cases (5 × 0.4%, 2 × 0.5%; histologically 1
chromoblastomycosis, 1 coccidioidomycosis, 1 histoplas-
mosis, 1 histoplasmosis or cryptococcosis, 1 mucormy-
cosis, only 1 myzetoma, and 1 rhinosporidiosis), the
same as for Nocardia cyriacigeorgica (7 × 0.2%; histologi-
cally 1 coccidioidomycosis, 1 histoplasmosis, 1 histoplas-
mosis or cryptococcosis, 1 mucormycosis, only 1
myzetoma, and 2 cases of rhinosporidiosis). For Nocar-
dia farcinica 8 cases (6 × 0.04%, 2 × 0.05%) and for Strep-
tomyces spp., eight cases (2 × 0.9%, 6 × 1%) (histologically
1 chromoblastomycosis, 1 coccidioidomycosis, 1
histoplasmosis, 1 histoplasmosis or cryptococcosis, 1
mucormycosis, only 1 myzetoma and 2 cases of rhinos-
poridiosis) were detected. Compared with the total num-
ber of reads, there were no detections above any
standard deviation in the ameba samples. In relation to
the bacteria-specific reads, there were detections above
only the 1st standard deviation in the fungal samples.
This involved Nocardia brasiliensis (6 × 0.2%) and Strep-
tomyces spp. (6 × 4%) in 6 samples (histologically 2 chro-
moblastomycosis, 1 mucormycosis, 2 mycetoma, and 1
rhinosporidiosis); Nocardia cyriacigeorgica (5 × 0.07%) in
5 samples (histologically 1 chromoblastomycosis, 1
histoplasmosis, 1 mucormycosis, 1 mycetoma, and 1 rhi-
nosporidiosis); and Nocardia farcinica in 3 samples (3 ×
0.2%) (histologically 1 chromoblastomycosis, 1 mucor-
mycosis, 1 mycetoma). In samples from patients with in-
vasive amebiasis, Nocardia cyriacigeorgica (0.1%) was
once above the 2nd standard deviation and Nocardia
farcinica (0.2%) was once above the 1st standard devi-
ation compared with the bacteria-specific reads.
Among the 6 assessed ameba samples, there were 2
samples with high ameba density microscopically in
Table 3 Detectable bacterial species and their relative
proportion of reads in the samples
Species Mean percentage of
reads in the sample
(± 1 standard deviation)
Mean percentage of bacterial r
eads in the sample
(± 1 standard deviation)
Nocardia
brasiliensis
0.021% ± 0.020% 0.097% ± 0.072%
Nocardia
cyriacigeorgica
0.009% ± 0.009% 0.044% ± 0.029%
Nocardia
farcinica
0.020% ± 0.019% 0.087% ± 0.066%
Streptomyces
spp.
0.458% ± 0.428% 2.283% ± 1.494%
Table 4 Mean percentage of reads of Entamoeba spp., E.
histolytica and E. dispar in the samples
Species Mean percentage of reads in
the sample (± 1 standard deviation)
Entamoeba spp. 0.000560% ± 0.002061%
E. histolytica 0.000398% ± 0.001875%
E. dispar 0.000109% ± 0.000107%
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adjacent histological sections and positive E. histolytica
PCR; 1 sample with only few amebas in histology in
neighboring sections and only questionable positive PCR
(cycle threshold value > 35); 1 sample with a positive
microscopic result that was questionable due to a very
low parasite density in adjacent histological sections and
negative PCR; as well as 2 samples with negative hist-
ology in adjacent sections and negative PCR results. Se-
quences of E. histolytica (0.009%) and Entamoeba spp.
(0.01%) were detected by NGS above the 4th standard
deviation in comparison with the total number of reads
in the samples in one of the strongly positive samples in
histology and PCR. In the same sample, sequences were
assigned to the phylogenetically closely related E. dispar
(0.0004%) above the 2nd standard deviation. Entamoeba
spp. sequences above the first standard deviation were
also detected in the sample with a few histologically vis-
ible amebas and a questionable PCR result (0.0003%)
and in one of the two samples with negative PCR and
negative histology (0.0004%) (Table 7). Furthermore,
there were Entamoeba spp.-specific sequences above
the 2nd standard deviation (0.0005%) in one chromo-
blastomycosis sample and above the 1st standard
deviation (0.0003%) in a mycetoma sample. E. dispar--
specific sequences were detected in the latter two
samples above the 1st standard deviation (each
0.0003%) as well.
Discussion
The NGS technology offers a molecular biological diag-
nostic tool that allows pathogen detection in complex
sample material without prior specific suspicion, if an
adequate sequence depth can be guaranteed. The ques-
tion of adequate sequence depth for metagenomic ana-
lyses is not easily answered, in particular, if the
proportion of pathogen DNA within a sample is un-
known. Most recently, it was suggested by Hillmann et
al. (https://www.biorxiv.org/content/biorxiv/early/2018/
Table 5 Comparison of the NGS Results in Terms of Percentage of Species-specific Reads of Investigated Fungal Species Per Total
Number of Reads in the Sample with the Respective Largest Standard Deviation above the Mean of All Samples in Multiples of the
Standard Deviation (SD), Depicted for the Samples from Patients with Invasive Mycoses. “Positive” =matching of the molecular results
with histology. “Negative” = inconsistency of molecular results with histology. “Partially positive” = detection of both matching and
nonmatching molecular results compared with histology. “Contaminated” = Detection of environmental fungi only. “Match” = NGS result
matching the histological findings. “Mismatch” = NGS results not matching the histological findings, “No match” = No evidence for
relevant fungal species above the respective standard deviation (SD), “Not performed” in “Specific PCR” = No specific PCR performed.
Highest standard deviations (SD) are shown
Sample Histological diagnosis Specific PCR [13] Panfungal PCRs [13] NGS > 1st SD NGS > 2nd SD NGS > 3rd SD NGS > 4th SD
1 Chromoblastomycosis Not performed Contaminated Matchd No match No match No match
2 Mucormycosis Negative Contaminated No match No match No match No match
3 Histoplasmosis Negative Contaminated Mismatche Mismatchf No match No match
4 Mucormycosis Positivea Contaminated No match No match No match Matchg
5 Histoplasmosis or cryptococcosis Negative Contaminated No match No match No match Matchh
6 Chromoblastomycosis Not performed Contaminated Mismatchi Matchj No match No match
7 Rhinosporidiosis Not performed Contaminated No match No match No match No match
8 Mycetoma Not performed Contaminated Mismatchk Mismatchl No match Matchm
9 Rhinosporidiosis Not performed Contaminated Mismatchn No match No match No match
10 Mycetoma Not performed Contaminated Mismatcho No match No match No match
11 Histoplasmosis Negative Contaminated No match No match No match No match
12 Histoplasmosis Negative Contaminated Mismatchp Mismatchq Mismatchr No match
13 Chromoblastomycosis Not performed Contaminated No match No match No match No match
14 Histoplasmosis Positive Partially positiveb No match No match No match Matchs
15 Coccidioidomycosis Not performed Contaminated Mismatcht No match No match No match
16 Coccidioidomycosis Not performed Contaminated No match No match No match No match
17 Mycetoma Not performed Partially positivec No match No match No match Matchu
aLichtheimia / Absidia corymbifera, bHistoplasma capsulatum in 2 out of 5 panfungal PCRs, cMadurella mycetomatis in 1 out of 5 panfungal PCRs, d0.004%
Cladophialophora yegresii, e0.0004% Capronia epimyces, f0.0002% Cladophialophora carrionii, g0.00004% Rhizopus oryzae, h0.00001% Cryptococcus carnescens,
i0.00009% Fusarium graminearum, j0.0002% Cladophialophora psammophila, k0.0004% Bipolaris oryzae, l0.0005% Paracoccidioides sp. ‘lutzii’, m0.02% Fusarium
pseudograminearum, n0.004% Cladophialophora yegresii, o0.004% Cladophialophora yegresii, p0.0003% Bipolaris sorokiniana, 0.004% Cladophialophora yegresii,
0.0003% Coccidioides immitis, 0.0004% Paracoccidioides sp. ‘lutzii’, q0.0006% Capronia epimyces, 0.0006% Chaetomium globosum, 0.0004% Chaetomium
thermophilum var. Thermophilum, 0.0002% Cladophialophora psammophila, 0.0002% Cryptococcus neoformans, 0.0002% Exophiala dermatitidis, 0.0006%
Paracoccidioides brasiliensis, r0.0005% Coccidioides posadasii, 0.0005% Cyphellophora europaea, 0.0002% Fusarium graminearum, s0.02% Histoplasma capsulatum,
t0.004% Cladophialophora yegresii, u0.001% Madurella mycetomatis. Matches with the histological findings are depicted in underlined print
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Table 6 Comparison of the NGS Results in Terms of Percentage of Species-specific Reads of Investigated Fungal Species Per Total
Number of Fungal Reads Only in the Sample with the Respective Largest Standard Deviation above the Mean of All Samples in
Multiples of the Standard Deviation (SD), Depicted for the Samples from Patients with Invasive Mycoses. “Positive” =matching of the
molecular results with histology. “Negative” = inconsistency of molecular results with histology. “Partially positive” = detection of both
matching and nonmatching molecular results compared with histology. “Contaminated” = Detection of environmental fungi only.
“Match” = NGS result matching the histological findings. “Mismatch” = NGS results not matching the histological findings, “No
match” = No evidence for relevant fungal species above the respective standard deviation (SD), “Not performed” in “Specific PCR” =
No specific PCR performed. Highest standard deviations (SD) are shown
Sample Histological diagnosis Specific PCR [13] Panfungal PCRs [13] NGS > 1st SD NGS > 2nd SD NGS > 3rd SD NGS > 4th SD
1 Chromoblastomycosis Not performed Contaminated No match Matchd No match No match
2 Mucormycosis Negative Contaminated Mismatche No match No match No match
3 Histoplasmosis Negative Contaminated Mismatchf Mismatchg Mismatchh No match
4 Mucormycosis Positivea Contaminated No match No match No match Matchi
5 Histoplasmosis or cryptococcosis Negative Contaminated No match No match No match Matchj
6 Chromoblastomycosis Not performed Contaminated No match Matchk No match No match
7 Rhinosporidiosis Not performed Contaminated No match No match No match No match
8 Mycetoma Not performed Contaminated No match No match No match Matchl
9 Rhinosporidiosis Not performed Contaminated Mismatchm No match No match No match
10 Mycetoma Not performed Contaminated Mismatchn No match No match No match
11 Histoplasmosis Negative Contaminated No match No match No match No match
12 Histoplasmosis Negative Contaminated No match No match No match No match
13 Chromoblastomycosis Not performed Contaminated No match No match No match No match
14 Histoplasmosis Positive Partially positiveb Mismatcho No match No match Matchp
15 Coccidioidomycosis Not performed Contaminated No match No match No match No match
16 Coccidioidomycosis Not performed Contaminated No match No match No match No match
17 Mycetoma Not performed Partially positivec Mismatchq Mismatchr No match Matchs
aLichtheimia / Absidia corymbifera, bHistoplasma capsulatum in 2 out of 5 panfungal PCRs, cMadurella mycetomatis in 1 out of 5 panfungal PCRs, d4%
Cladophialophora yegresii, e3% Cladophialophora yegresii, f0.2% Cryptococcus neoformans, 0.6% Chaetomium globosum, g1% Capronia epimyces, h0.6%
Cladophialophora carrionii, i0.05% Rhizopus oryzae, j0.01% Cryptococcus carnescens, k0.8% Chaetomium globosum, 0.4% Cladophialophora psammophila, l16%
Fusarium pseudograminearum, m3% Cladophialophora yegresii, n3% Cladophialophora yegresii, o0.09% Cryptococcus gattii, 0.4% Paracoccidioides brasiliensis,
p34% Histoplasma capsulatum, q0.7% Capronia epimyces, r0.2 Exophiala dermatitidis, 0.5% Chaetomium thermophilum var. Thermophilum, 1% Chaetomium
globosum, s4% Madurella mycetomatis, Matches with the histological findings are depicted in underlined print
Table 7 Comparison of the NGS Results in Terms of Percentage of Species-specific Reads of Investigated Entamoeba spp., Entamoeba
histolytica, and Entamoeba dispar Per Total Number of Reads in the Sample with the Respective Largest Standard Deviation above the
Mean of All Samples in Multiples of the Standard Deviation (SD), Depicted for the Samples from Patients with Invasive Amebiasis.
“Positive” = positive Entamoeba histolytica PCR. “Negative” = negative Entamoeba histolytica PCR. “Uncertain” (for “Specific PCR”) = High
cycle threshold value > 35 in real-time PCR with associated uncertain interpretation. “Uncertain” (for “Microscopy in neighboring slides”)
= Extremely low parasite density with associated uncertain interpretation. “Match” = NGS result matching the diagnosis “invasive
amebiasis”. “Partial match” = NGS result matching the diagnosis “invasive mycosis” on genus level only, so it is neither confirmed nor
completely rejected, “Mismatch” = NGS results not matching the diagnosis “invasive amebiasis”, “No match” = No evidence of specific
sequences above the respective standard deviation (SD). Highest standard deviations (SD) are shown
Sample Histological diagnosis Specific PCR [7] Microscopy in neighboring slides [7] NGS > 1st SD NGS > 2nd SD NGS > 3rd SD NGS > 4th SD
18 Invasive amebiasis Positive Many amebae No match No match No match No match
19 Invasive amebiasis Negative Negative No match No match No match No match
20 Invasive amebiasis Positive Many amebae No match Mismatcha No match Matchb
21 Invasive amebiasis Uncertain Few amebae Partial matchc No match No match No match
22 Invasive amebiasis Negative Negative No match No match No match No match
23 Invasive amebiasis Negative Uncertain Partial matchd No match No match No match
a0.0004% Entamoeba dispar, b0.009% Entamoeba histolytica and 0.01% Entamoeba spp., c0.0003% Entamoeba spp., d0.0004% Entamoeba spp.
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05/12/320986.full.pdf, last accessed on 1 August 2018)
that shallow metagenomic analysis effectively probes the
diversity of species down to a sequencing depth of ~
500 k reads per sample. Even better sequence depth was
achieved for all described samples by our sequencing
approach.
The technological approaches of NGS are varied [9,
19–25] and some are still in the stage of development
or optimization. A descriptive overview on NGS for
the diagnosis of infectious diseases was introduced by
Hasman and colleagues [26]. In a previous study, an
association between infectious agents and a disease of
unknown origin was confirmed [14]. Further,
NGS-based detection of bacterial pathogens from
two-thirds of tested urine samples was demonstrated
in a previous “proof-of-principle” investigation [26].
NGS is also suitable for the detection of
poly-microbial infections, as was shown for sample
material from brain abscesses [27]. The most reliable
diagnostic information can be provided by NGS from
primary sterile sample material, where few reads can
be used for pathogen diagnostics. Thus Wilson and
colleagues succeeded in demonstration of Leptospir-
a-induced meningoencephalitis with NGS based on
only 475 (out of more than 3 million) specific reads
[28]. Pathogen identification with NGS-based analysis
of RNA (ribonucleic acid) in the sample material is
also possible and succeeded in recognizing RNA vi-
ruses such as influenza virus in respiratory samples in
the so-called UMERS (“unbiased metagenomic nontar-
geted RNA sequencing”) approach [29].
Although the NGS technology is still expensive, se-
quencing costs have dropped dramatically. For example,
the cost of sequencing a human genome was reduced
from about 100,000 euros to about 1000 euros within a
few years as a result of technological progress [9]. In
particular, the introduction of small automated
sequencers (about the size of laser printers) has made
NGS technology interesting for diagnostic purposes. An
earlier comparative evaluation of these small “work-
bench” sequencers showed that the MiSeq system (Illu-
mina) that was used in this study is superior to the
competitors Ion Torrent PGM (Life Technologies, Carls-
bad, CA, USA) and the no-longer available 454 GS Jun-
ior (Roche, Basel, Switzerland) with focus on the rarity
of sequencing errors [30].
The hitherto quite complex and non–user-friendly
analysis of sequence information is currently one of
the major limitations of wide diagnostic application of
NGS technology [31]. Further automation and
standardization are essential to overcome these prob-
lems for the application of NGS in diagnostic routine.
This also applies to the quality and accessibility of
underlying databases.
Although the application of NGS with formalin-fixed,
paraffin-embedded tissue is not new [17, 18], the
NGS-based detection of etiologically relevant pathogens
from such materials is a diagnostic challenge. In addition
to previous experiments, we therefore conducted a
real-life assessment with sample materials from patients
with rare and tropical invasive infections, for which no
similar experience is available. Non-pathogen-specific
molecular diagnostic approaches such as NGS are easily
affected by contamination due to environmental micro-
organisms that are, for example, cast along with the
sample in wax. As shown for Bartonella spp. DNA some
years ago [32], DNA cross-contamination during tissue
processing in a multispecies histopathological laboratory
is highly likely. In the current, still unpublished, EORTC
(European Organization for Research and Treatment of
Cancer) criteria (personal correspondence with Professor
Ralf Bialek) for the detection of a fungal infection from
paraffin-embedded tissue by means of PCR, it is expli-
citly pointed out that the detection of specific fungal
DNA in paraffin-embedded tissues shall only be used as
proof of infection if fungal elements are also seen in
histopathological assessments. This is to make sure that
possible contamination of paraffin with ubiquitous fun-
gal spores, for example of Aspergillus spp., is not mis-
takenly used as evidence of invasive mycosis. Although
protocols for optimizing the use of FFPEs in molecular
epidemiology by reducing the contamination risk have
been introduced [33], initial tissue processing and wax-
ing had been performed in a histopathological standard
laboratory, where no special precautions against DNA
contamination had been enforced. During the cutting of
the sections for the molecular analyses, protective proce-
dures against contamination such as discarding the first
cuts of each block had been enforced as detailed else-
where [7, 13]. However, such precautions cannot undo
contamination with fungal spores or pathogen DNA that
has already occurred during initial processing and wax-
ing of the tissue. This problem was also evident in the
present study, in terms of both pan-fungal PCRs and the
NGS approach. Traces of DNA even of rare tropical
pathogens could be identified within the samples.
Species-specific PCRs [34–41] are potential alternatives
to pan-fungal PCR approaches, but their selection re-
quires a specific diagnostic suspicion.
Traditional histology is not always reliable in case of
invasive fungal infections as well. Its reliability is influ-
enced by a variety of factors, including the requirement
for a critical minimum density of pathogens in the ex-
amined tissue and a high level of expertise of the phys-
ician. In comparative studies between histology and
culture, the latter of which cannot be performed from
formalin-fixed tissues, a match of less than 80% was
demonstrated [42], so histological diagnoses of invasive
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mycoses have to interpreted with caution [36]. In this
study, the histological evaluation was performed by expe-
rienced pathologists who were professionally experienced
in tropical infectious diseases [13]. Particularly considering
the large number of genera and species that—as shown in
the “Material and Methods” section—may account for the
assessed invasive fungal infections, one has to bear in
mind that histologically indistinguishable findings may be
caused by different agents. In most cases of invasive myco-
sis in this study, histology did not allow a species-specific
diagnosis but only micro-morphological descriptions such
as chromoblastomycosis, mucormycosis, or mycetoma.
The lack of cultural and serological results makes the
interpretation of such findings challenging, which is an
undeniable limitation of this study. Molecular approaches
can be very useful here if culture is not possible. Even
when sampling conditions allow culture approaches, cul-
tural growth is not possible for all invasive fungi and takes
between several days and several weeks depending on the
species, as summarized elsewhere [13]. These factors re-
duce the diagnostic value of fungal culture.
A first important precondition for the reliability of
molecular diagnostic findings is the quality of the nu-
cleic acid extraction, which in this study was unaccept-
able for several samples that had been stored for long
times. In line with this, partial PCR inhibition was
observed in some of the assessed samples, as shown
elsewhere [13]. Comparative testing of alternative
nucleic acid purification methods [43, 44] might have
contributed to a further optimization of nucleic acid
preparation in this study, but this was impossible due to
the small amount of sample material that was available,
which is an undeniable limitation of the study. For the
samples that could be included in the NGS assessment,
no significant Spearman rank correlation between sam-
ple age and number of detected reads could be found.
However, the heterogeneity of the sample materials used
makes an interpretation difficult. Of note, no samples
older than 31 years were included.
Since the paraffin blocks were stored with the
formalin-fixed tissues for years without any special pro-
tective measures against the deposition of fungal spores,
contamination with environmental fungal spores can be
regarded as highly probable. Thus, the high levels of
contamination with environmental fungi are not unex-
pected. Contamination of the paraffin is an alternative
explanation.
The high degree of contamination, expected from the
previously applied pan-fungal PCRs [13], was a challenge
for the NGS analysis. Since NGS analysis is associated
with a completely nonspecific analysis of DNA frag-
ments, the challenge is the discrimination of contami-
nants and etiologically relevant pathogens. The
histological results of the samples from patients with
invasive mycosis provided hints but not etiological clari-
fication at the species level.
To overcome this problem, each mean value and
standard deviation of the percentages of specific se-
quence fragments (reads) of etiologically relevant species
were determined in the assessed samples. Then, the
standard deviation from the average at which matching
with the histological results can be expected was
investigated.
A high rate of matches between histology and NGS re-
sults was found only for percentages above the fourth
standard deviation in relation to the total number of
reads and the number of fungi-specific reads. In cases
with percentages above the fourth standard deviation,
clear similarities with histology were found. When the
percentages in relation to the totality of the reads in the
sample were compared with the percentages in relation
to the fungal reads in the sample, there was a consider-
able deviation, which can be explained by the massive
differences in the proportions of assignable reads as well
as eukaryotic, bacterial, and viral reads. For samples in
which none of the assessed species reached the 4th
standard deviation, no reliable assignment of etiological
relevance could be performed. In the 6 tested samples
from patients with invasive amebiasis, NGS-based detec-
tion of E. histolytica succeeded in a single sample only,
which had also been positive in histology and was clearly
positive by PCR.
The approach of comparing NGS results from non-
sterile samples of patients with results from a healthy
population to define etiologic relevance is not new. A
comparison with negative control samples, which was
based on a specific subtraction of reads, has been pro-
posed by other authors as a method for identifying path-
ogens of potential etiological relevance. In this way, the
detection of shiga-toxin-producing Escherichia coli suc-
ceeded in 67% of stool samples of patients during an
outbreak [15].
Another approach was chosen for the sample collec-
tion assessed in this study. Other than in the recently
described study [15], historical sample materials were
used in the real-life assessment presented here. Because
the samples had not been stored and collected for study
purposes but as part of the diagnostic routine, no
matched standardized negative control samples had been
prepared. The collection of corresponding materials
from completely healthy control subjects would also
have posed an ethical problem in instances where the
materials were derived from severely invasive sampling
procedures, e.g., in case of samples from lung tissue,
spinous process tissue, or tricuspid valve tissue. In any
case it is obviously impossible to retrospectively apply
any sort of standardization to samples prepared, paraffi-
nated, and stored under unknown, and presumably
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variable conditions in comparatively low-tech laboratory
environments sometimes a considerable time in the past.
Although randomly selected blocks from a similar time
frame that were negative by histopathology might have
helped to establish an expected background, such an ap-
proach was not chosen for the above-mentioned
reasons.
To overcome the problem of the lack of standardized
negative controls, the mean percentages of specific reads
from all samples, including histologically positive and
negative ones regarding the various assessed species,
were considered as proxy-negative control values, repre-
senting an averaged background. The repeated summing
of the standard deviation values and comparison with
the individually measured percentages in each sample
allowed an estimation of how many more specific reads
were detected in each sample than in the proxy-negative
control. Accordingly, a standard deviation-based and not
a subtraction-based approach [15] was chosen.
The rationale of the standard deviation-based ap-
proach is the assumption that the likelihood of a real in-
fection increases with the number of standard deviations
of a percentage of measured specific reads in a specific
sample above the proxy-negative control. With a value
high above the mean value plus several standard devia-
tions, the risk is low that this percentage is measured by
chance, i.e., due to contamination. If bacteria and fungi
were assessed, these comparisons were carried out not
only with all reads within the samples but also with bac-
teria- or fungi-specific reads. This was done to reduce
the effects of the slightly different proportions of viral,
bacterial, fungal, and other eukaryotic reads specific to
the sample materials. As amebae are neither fungi nor
bacteria, such an approach was not possible for their
assessment. As an indication of potential contamination,
the percentages of specific reads for all species of the
genus Entamoeba and also of specific reads for
non-pathogenic amebae such as E. dispar were assessed.
For the fungi and bacteria that were assessed, compari-
sons of the species-specific reads with the total number
of reads and with fungus-specific reads and
bacteria-specific reads, respectively, led to slightly differ-
ent results. For example, there were matches above the
2nd standard deviation for Cladophialophora psammo-
phila compared with the total number of reads and for
both Cladophialophora psammophila and Chaetomium
globosum compared with the fungus-specific reads in a
sample with the histological diagnosis of chromoblasto-
mycosis. Such differences are mathematical artifacts
resulting from slightly different proportions of
fungus-specific reads in the different sample materials.
Such examples demonstrate the vulnerability of the
model, which is a particular problem with low sample
numbers when slight variances show large effects.
An undeniable limitation of the standard deviation-based
approach is the fact that the reliability of the proxy-negative
control will depend on the number of assessed samples.
However, subtraction-based approaches [15] are also sus-
ceptible to the problem of sample numbers in excluding
major effects of variations by chance.
It is likely that the variety of anatomical source sites
might influence the quality of the proxy-negative con-
trol. The fact that samples from primarily sterile body
compartments were also severely contaminated with
DNA of various non-human species suggests that the
effects of procedures subsequent to sample acquisition,
e.g., during processing, paraffination and storage, were
more relevant to the measured contamination than was
the anatomical sampling site. Accordingly, the anatom-
ical site was not specifically considered in the definition
of the proxy-negative control for the formalin-fixed,
paraffin-embedded tissue samples that were assessed.
For medical interpretation of the diagnostic NGS results,
however, the natural occurrence of environmental mi-
croorganisms on primarily non-sterile sampling sites has
to be considered. Thus NGS cannot do away with the
need for medical validation and interpretation of diag-
nostic findings.
No target enrichment, e.g., by specific PCR, was
attempted or evaluated because the performance of diag-
nostic NGS without specific suspicion was being
assessed. Depletion of human DNA prior to the NGS
runs was also not attempted, because the initial DNA
quantities in the historical samples was so low that the
appropriate technical strategies might also have affected
the recovery of the residual target DNA. As an example
of this concern over sensitivity, pro-viral DNA of HIV
that would be anticipated to be present was never de-
tected in any sample of the patients with invasive and
tropical mycoses. The sensitivity concern is of particular
importance, because various matches with the histo-
logical diagnoses were achieved with just the standard
deviation-based approach for the attribution of etio-
logical relevance, while the total numbers of specific
reads were very low. In contrast, etiologically irrelevant
environmental fungi dominated among the most fre-
quently detected fungal reads in nearly all samples
assessed.
Another pointer toward unlikely etiological relevance
but increased likelihood of contamination is the frequent
detection of very rare pathogens in various samples. An
example is the frequent detection of Cladophialophora
yegressii, which lives on living cactus plants [45]. Al-
though Cladophialophora spp. can in rare cases be asso-
ciated with human disease, i.e. chromoblastomycosis
[45], the frequent occurrence of comparably high DNA
concentrations in samples without any histological indi-
cations for chromoblastomycosis makes it more likely
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that there was contamination deriving from cactus
plants in the diagnostic institute.
Further, interpretation can be difficult if increased
quantities of sequences of a species are detected which
has rarely or never been associated with clinical disease
so far. Cryptococcus carnescens is such an example. C.
carnescens is part of the Cryptococcus laurentii complex
[46]. In a recent review on non-neoformans cryptococcal
infections, only 20 cases of infection with C. laurentii
complex were reported [47] and those were without de-
tailed differentiation within the complex. The etiological
relevance of the C. carnescens sequences, which were
identified by NGS in sample 5 of a patient with the
histological diagnosis of histoplasmosis or cryptococ-
cosis, is therefore uncertain.
Although potentially useful diagnostic information for
5 out of 17 samples from patients with invasive fungal
infection (29.4%) and for 1 out of 6 samples from pa-
tients with invasive amebiasis (16.7%) represents only a
modest result, this result must be interpreted in relation
to the complexity of the sample materials. The sensitiv-
ity of the procedure is, undeniably, still unacceptably
poor. In comparison, the molecular gold standard
method of pan-fungal PCRs with subsequent Sanger se-
quencing allowed conclusive detection of pathogens in
only 2 out of 17 fungal samples (11.8%) and even that
only in 3 out of 10 PCR reactions for those 2 samples
[13]. In contrast, NGS analysis not only allowed con-
firmation of the pan-fungal PCR detections of Histo-
plasma capsulatum and Madurella mycetomatis but
also gave hints of infections due to Rhizopus spp., Cryp-
tococcus spp., and Fusarium spp. Particularly for assign-
ments at genus and species levels, histology showed
limited value for the diagnosis of invasive fungal infec-
tions [36, 42], as in the study described here. For the de-
tection of Entamoeba histolytica in intestinal biopsies,
however, specific PCR proved to be superior to NGS
analysis.
Accordingly, NGS analysis can help to improve the
molecular discrimination of fungal pathogens in
formalin-fixed, paraffin-embedded tissues in comparison
with contamination-sensitive pan-fungal PCR with sub-
sequent Sanger sequencing. However, the sensitivity ap-
pears inferior to that of specific PCR approaches, as the
experiments with the ameba-containing samples suggest.
For the invasive fungi, however, quality-controlled spe-
cific PCRs were available only for histoplasmosis and
mucormycosis in the laboratories of the study partici-
pants. Specific analysis for all fungal pathogens could
therefore not be performed—an admitted limitation of
the study.
Focusing on samples for which results of specific PCR
and Sanger sequencing were available, it is interesting
that PCR with subsequent Sanger sequencing suggested
Lichtheimia/Absidia corymbifera while NGS gave strong
hints for Rhizopus oryzae in sample 4 of a patient with
mucormycosis. Preferential amplification of Lichtheimia/
Absidia corymbifera DNA by the PCR primers is a likely
explanation, while the more abundant Rhizopus oryzae--
specfic DNA was identified by NGS. Preferential primer
binding affinities of multispecies primers to certain mi-
croorganisms is a well-known problem affecting
amplification-based diagnostic approaches [48].
With focus on the hypothesis of the study, it could be
shown that hypothesis-free genomic detection of rare in-
vasive infections by NGS in poly-microbially contami-
nated, formalin-fixed, paraffin-embedded tissue samples
is feasible and can provide hints on likely causative
agents. Considering the cost of the technique, the de-
manding technical and bioinformatic procedures, and
the uncertainties regarding the interpretation of the re-
sults, the technique at present is still subordinate in the
diagnostic workflow and should be only considered if
other, less demanding procedures do not lead to conclu-
sive results.
It should be noted that assignment of potential etio-
logical relevance based on a percentage of specific NGS
reads is far from being standardized and requires further
evaluation. Among other factors, the choice of the num-
ber of negative control samples in the calculation of the
average of the percentage values of reads will necessarily
have an impact on the size of the standard deviation and
thus on the potential attribution of etiologic relevance in
contaminated sample materials. So, standardization prior
to diagnostic use is obligatory. From this perspective, the
results presented here can only be considered as
hypothesis-forming. Further studies are needed to define
standards for medical interpretation of NGS-based patho-
gen identification directly from sample material. This
applies even more strongly for contamination-prone sam-
ple materials such as formalin-fixed, paraffin-embedded
tissue samples.
For such contamination-prone sample materials, there
is considerable risk of false-positive spurious results, e.g.,
in case of contamination events that are restricted to the
processing of individual samples. Such events cannot be
controlled by the proxy-negative control-based standard
deviation approach. Accordingly, the procedure we have
introduced can only lead to hypothesis-forming results
that will induce the clinician in charge to consider as dif-
ferential diagnoses clinically matching infectious diseases
that had not been considered prior to the non-specific
NGS assessment. Without consideration of the clinical
findings, the NGS results from such materials are not in-
terpretable. If these limitations are accepted, however,
NGS can help to suggest infectious agents as potentially
etiologically relevant that were not considered during
the initial clinical assessment of a patient. With this aim,
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the technique can be applied in situations when there
are no clear candidates in the potential etiological back-
ground of clinical situations in infectious disease
patients.
Conclusions
In conclusion, molecular diagnostic approaches from
complex and potentially contaminated sample materials
such as formalin-fixed, paraffin-embedded tissues re-
main a challenge. Similarly to previous studies [14], po-
tentially etiologically relevant species that could not be
detected by traditional molecular analysis were identified
by NGS. The findings suggest the suitability of the use
of NGS-based diagnostics on materials taken under ster-
ile precautions from primary sterile compartments of
the body even without a specific etiologic suspicion.
A major disadvantage of pathogen-nonspecific NGS
analysis remains the low sensitivity in comparison with
specific PCR, which was confirmed by the example of the
ameba samples and which was also observed by other au-
thors [49]. Another disadvantage, as addressed in this
study, is the high susceptibility to contamination that is
frequently observed in formalin-fixed, paraffin-embedded
samples. It must further be considered that the procedure
described is both expensive and time-consuming. The cost
of the reagents employed for this proof-of-principle as-
sessment was about 50,000 euros, apart from payment for
the scientists and technical assistants. The diagnostic
approaches including the nucleic acid processing, the
NGS runs, the programming and application of the re-
quired bioinformatics, and the interpretation of the data
occupied several weeks. Both the costs and the long
time-to-result will impede the use of the procedure for
routine-diagnostic purposes in the near future.
Following this “proof-of-principle” study, validations
with larger numbers of samples should be performed to
define reliable standards for the discrimination of the
detection of etiologically relevant pathogens from the
detection of nucleic acid contamination, in particular
from difficult sample materials.
Methods
Sample materials
The materials assessed comprised residual extracted nu-
cleic acids from two previous studies [7, 13], that is,
from 17 FFPE tissue samples with histological evidence
of invasive mycosis by tropical or rare fungi and 34 sam-
ples from patients with invasive amebiasis. Information
on the applied nucleic acid extraction procedures is
summarized in Table 8.
As detailed below, only 6 out of 34 amebic samples of
the original collection [7] could be included into the
NGS assessment on the grounds of sufficient quality and
quantity of the DNA. The histopathological diagnoses of
the patients with invasive mycoses were chromoblastomy-
cosis (n = 3), coccidioidomycosis (n = 2), histoplasmosis (n
= 4), histoplasmosis or cryptococcosis with histologically
difficult discriminability (n = 1), mucormycosis (n = 2),
mycetoma (n = 3), and rhinosporidiosis (n = 2) as detailed
elsewhere [13] (Table 9).
Cultural and serological diagnostic results were not
available. Further, there were no data on previous mo-
lecular diagnostic assessment from the time of sample
acquisition or on microscopical assessments from other
sample materials, e.g., for ova or parasites from stool
samples.
The sample collection included biopsies of the intes-
tinal mucosa (n = 6), lymph node tissues (n = 2), skin bi-
opsies (n = 6), bioptic material from a nasal polyp (n =
1), cells from vaginal discharge (n = 1), lung tissue (n =
2), bone, muscle, and connective tissue from the spinous
process of the third thoracic vertebra (n = 1), tissue of a
tricuspid valve (n = 1), a lower lip biopsy (n = 1), an eth-
moid sinus biopsy (n = 1), and bioptic material from a
wound on a foot (n = 1). The sample age at the time of
nucleic acid extraction varied between 1 and 31 years
with a mean of 11.5 years (± 6.1) in a left-shifted distri-
bution for the fungal samples and with a mean of 25.8
years (± 4.3) in a right-shifted distribution for the
ameba-containing samples. All samples had been stored
in the Department of Pathology of the Bernhard Nocht
Institute for Tropical Medicine in Hamburg, Germany.
Nucleic acid extraction procedures have been de-
scribed elsewhere [7, 13]. Photometric nucleic acid
quantification was done as described [13] with a Pico
100 Picodrop Microliter Spectrophotometer (Picodrop
Ltd., Hinxton, UK) and indicated DNA concentrations
of 123.6 (±166.5) ng/μl for the fungal samples and 25.1
(±30.2) ng/μl for the amebic samples.
In addition to microscopic assessment [7, 13], all
amebic samples had been assessed by E. histolytica-s-
pecific PCR [7], while the fungal samples had been
characterized by five different pan-fungal PCRs with
subsequent Sanger sequencing as well as Histoplasma
spp.-specific and Mucorales-specific PCR, the latter
also with Sanger sequencing [13] (Table 10). If se-
quences of environmental fungi in contradiction to
the histological diagnosis were detected by pan-fungal
PCR or if sequence overlays made the interpretation
of Sanger sequencing results of pan-fungal PCR prod-
ucts impossible, contamination of the samples with
environmental fungi was assumed. Table 10 lists all
used primers and probes including the inhibition con-
trol PCR and the sample quality control PCR. Rele-
vant sample inhibition was not shown for the
samples, as detailed elsewhere [7, 13]. Negative con-
trols also assessing the nucleic acid extraction proced-
ure and the master mixes using PCR-grade water
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were included in the PCR procedures. However, only
the sample materials were assessed by NGS.
NGS and bioinformatics
Nonspecific NGS sequencing of the DNA elements
within the samples was performed by an experienced
medical-laboratory assistant using a MiSeq system (Illu-
mina, San Diego, CA, USA) as described by the manu-
facturer. No target enrichment or human DNA
depletion was attempted. In summary, DNA libraries
were prepared using TruSeq® Nano DNA Sample Prep-
aration kits (Illumina) employing the low sample (LS)
protocol. Briefly, 100 ng of each genomic DNA from the
samples was fragmented by Adaptive Focused Acous-
tics™ Technology (Covaris, Inc., Woburn, MA, USA)
using a Covaris M220 with settings for fragment sizes in
the 350 bp range (duty factor 20%, peak incident power
50W, cycle per burst 200, duration 65 s, temperature 65
°C). Fragmented chromosomal DNA was cleaned up
with bead technology. End repair was performed accord-
ing to the TruSeq protocols. Further clean-up and size
selection was done with bead technology. 3′-Ends were
adenylated, Illumina adapters were ligated and DNA
fragments were enriched. An Agilent DNA 7500 kit
(Agilent Technologies, Inc., Santa Clara, CA, USA) was
used as a quality check and for the confirmation of the
intended fragment size after the application of the Cov-
aris M220 fragmentation protocol and after Illumina
adapter ligation. Visualization of a clearly defined peak
in the expected size range was considered as proof of
successful DNA fragmentation and adapter ligation. If
no peak was visible after applying the fragmentation
protocol, the sample was not further analyzed for down-
stream processing. Only samples with clearly visible
peaks in the expected size range, both after fragmenta-
tion and after adapter ligation, were further analyzed by
sequencing. No concentration determination by integrat-
ing the area under the peak was performed, because this
was considered as not reliable and sensitive enough for
sequencing. Actual library DNA concentration measure-
ments were performed using Qubit dsDNA BR assay kits
(Thermo Fisher Scientific, Waltham, MA, USA) prior to
loading the sequencing cells.
All 17 fungal samples were included in the further
analysis while only 6 amebiasis samples showed visible
DNA peaks and could thus be included. The remaining
28 amebiasis samples with visible DNA peaks lacking in
the Agilent system were discarded. Each individual li-
brary was adjusted to a 4 nmol/L stock solution and of
these 6 pmol was used for each individual sequence run.
Sequencing was performed using Reagent Kit MiSeq® v3
(600 cycle) runs (Illumina), with a complete v3 run used
per sample. Between 3 million and 23 million read pairs
were sequenced per sample. Considering an average
trimmed read length of 250 bp (base pairs) and an as-
sumed target genome of 30Mb (mega bases), this would
result in theoretical coverages in the range of 45 to
384-fold.
The bioinformatic processing of the resulting files was
performed at the Max Planck Institute for Heart and
Lung Research in Bad Nauheim, Germany. Paired-end
reads were trimmed for adapter sequences using Cuta-
dapt 1.41 [50]. All Truseq adapters were removed using
default parameters. The resulting reads were further
trimmed and filtered for quality using Trimmomatic
0.33 (LEADING:3, TRAILING:3, SLIDINGWIN-
DOW:5:20, MINLEN:30) [51]. Start and end of reads
were always trimmed by a fixed number of 3 nucleotides
to remove pervasive low-quality data. Furthermore,
reads were trimmed after a drop in average quality
below Q20 in a window of 5 nucleotides. Only if both
mates of a read-pair still contained more than 30 nucle-
otides after this, the pair was cleared for further analyses.
Kraken version 0.10.6 was employed to classify metage-
nomic reads based on matching 31-kmers with a confi-
dence threshold of 0.1 [52]. The reference database
consisted of genomes (*.genomic.fna.gz) of all bacteria,
viruses, fungi, and protozoa, as well as Homo sapiens
available from the RefSeq database on September 14,
Table 8 Nucleic Acid Extraction Procedures As Described
Elsewhere [7, 13]
Common procedures for formalin-fixed, paraffin-embedded (FFPE)
samples with histological diagnosis of invasive amebiasis and mycosis
• Exposure of 25 μm thick sections in 1.5 ml tubes for 2 × 10 min to
1200 μl xylene and for 3 × 10 min to 1200 μl 100% ethanol under
gentle constant agitation for deparaffination
• Discarding of the supernatant following each 10-min step after
centrifugation for 10 min at 13,000 g
• Air-drying of the samples
Specific procedures as applied for the samples with invasive mycosis
• DNA extraction using the DNA FFPE tissue kit (Qiagen, Hilden,
Germany) according to the manufacturer’s instruction as follows:
○ Proteinase K digestion at 56 °C overnight to get a clear
suspension
○ Lysis of the fungal cell walls in the pellet with 400 units of
Arthrobacter luteus lyticase L2524 (Sigma-Aldrich Corporation, St.
Louis, MO, USA) (instead of lyticase L4276 [Sigma-Aldrich
Corporation] which was no longer available) per sample for 45 min
at 37 °C
Specific procedures as applied for the samples with invasive amebiasis
• Tissue digestion in 200 μl lysis buffer (0.5% Tween 20 [ICI, American
Limited, Merck, Hohenbrunn, Germany], 2 mg/ml proteinase K [Roche,
Mannheim, Germany], 3.5 mM MgCl2, 15 mM ammonium sulfate, and
60 mM Tris/HCl [pH 8.5]) for at least 1 h until a clear lysate was
obtained at 56 °C under continuous shaking
• Boiling for 10 min to stop the digestion by denaturing the
proteinase K
• DNA extraction using the QIAamp DNA Mini Kit (Qiagen) according
to the manufacturer’s instructions
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2015 (ftp://ftp.ncbi.nlm.nih.gov/refseq/release/). The
classification was visualized using Krona 2.6 [53].
The analyzed sequence data sets were stored in the
database Sequence Read Archive (Sequence Read Arch-
ive (SRA) study accession SRP091494). In addition, the
data sets can be provided by Bernd Kreikemeyer on
request.
Evaluation
The NGS results were visualized by means of the Krona
software [53] and initially analyzed according to the fol-
lowing criteria: total number of reads (single sequence
fragments); number and percentage of nonassignable
reads in comparison with the NCBI RefSeq database;
and finally the percentages of human, protozoan, bacter-
ial, archaean, viral and fungal sequences. Among the
fungal sequence reads, the three most frequent fungal
species were identified in each sample material.
All samples were also searched for specific sequences
that could be assigned by the software Kraken to patho-
gens that were potentially relevant as causal agents for
the 23 study materials and their histologically diagnosed
pathologies. In this assessment, disease patterns that are
defined by their pathogens, such as E. histolytica-asso-
ciated amebiasis, histoplasmosis (caused by Histoplasma
capsulatum), cryptococcosis (caused by Cryptococcus
spp.), and coccidioidomycosis (caused by Coccidioides
spp.) were relatively easy to assign. Some of the invasive
mycoses studied can be caused by a wide variety of
potential pathogens. Because a possible etiologic rele-
vance of E dispar in invasive amebiasis has been dis-
cussed repeatedly [54–57], this species was also included
in the evaluation.
Potential relevant pathogens for poly-causal infectious
diseases [58–61] are summarized in Table 11.
The percentage of pathogen-specific sequence frag-
ments (paired reads) in relation to all reads in the sam-
ple was calculated and, if applicable, also in relation to
the fungus/bacteria-associated reads. To define the fre-
quency of such verified reads with diagnostic signifi-
cance as opposed to DNA contamination, i.e. influx
from the environment, during sample preparation,
Table 9 Histological Characterization of Neighboring Sections of the Materials That Were Used for NGS Assessment. Samples of
Cases with Invasive Mycosis Had Been Assessed by HE, Giemsa, PAS, and Grocott Staining [13], Samples of Cases with Invasive
Amebiasis by PAS Staining [7]. Especially in the Case of Filamentous Fungi, No Quantification Had Been Attempted, Because Elements of
a Multiply-cut Filament Were Indistinguishable from Single Cuts of Multiple Filaments
Sample Histological diagnosis Microscopic confirmation of pathogens in neighboring sections of the materials for NGS assessment
1 Chromoblastomycosis Microorganisms seen, no quantification performed
2 Mucormycosis Microorganisms seen, no quantification performed
3 Histoplasmosis Microorganisms seen, < 10 pathogens per unit area (160 μm× 210 μm)
4 Mucormycosis Microorganisms seen, no quantification performed
5 Histoplasmosis or cryptococcosis Microorganisms seen, < 10 pathogens per unit area (160 μm× 210 μm)
6 Chromoblastomycosis Microorganisms seen, no quantification performed
7 Rhinosporidiosis Microorganisms seen, no quantification performed
8 Mycetoma Microorganisms seen, no quantification performed
9 Rhinosporidiosis Microorganisms seen, no quantification performed
10 Mycetoma Microorganisms seen, no quantification performed
11 Histoplasmosis Microorganisms seen, < 10 pathogens per unit area (160 μm× 210 μm)
12 Histoplasmosis Microorganisms seen, < 10 pathogens per unit area (160 μm× 210 μm)
13 Chromoblastomycosis Microorganisms seen, no quantification performed
14 Histoplasmosis Microorganisms seen, < 10 pathogens per unit area (160 μm× 210 μm)
15 Coccidioidomycosis Microorganisms seen, no quantification performed
16 Coccidioidomycosis Microorganisms seen, no quantification performed
17 Mycetoma Microorganisms seen, no quantification performed
18 Invasive amebiasis Microorganisms seen, > 5 pathogens per unit area (160 μm× 210 μm)
19 Invasive amebiasis Negative microscopy in neighboring sections
20 Invasive amebiasis Microorganisms seen, > 5 pathogens per unit area (160 μm× 210 μm)
21 Invasive amebiasis Microorganisms seen, < 0.5 pathogens per unit area (160 μm× 210 μm)
22 Invasive amebiasis Negative microscopy in neighboring sections
23 Invasive amebiasis Uncertain microscopic result in neighboring sections
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averages of the percentages of the pathogen-specific
reads were calculated including all samples. Then, it was
established for which individual samples the detected
percentages of pathogen-specific reads exceeded the 1st,
2nd, 3rd, and 4th standard deviations above the mean of
all examined histologically positive and negative samples
(in terms of potential cut-off values). In this context,
“negative samples” mean samples with histological re-
sults that do not match the respective NGS-based iden-
tified pathogen. For these samples with larger than
average proportions of specific pathogen sequences,
NGS-based diagnosis was compared with histological
diagnosis to examine the diagnostic reliability of such
standard deviation–based thresholds.
Ethics
Ethical approval for this retrospective study using re-
sidual materials was granted by the Ethics Committee of
Table 10 PCR Oligonucleotides Used for the Molecular
Characterization of the Samples [7, 13, 62, 63]
Pan-fungal PCR 1 (variable 18S rRNA gene region)
Forward primer RTP_1 5′-ATT-GGA-GGG-CAA-GTC-TGG-TG-3′
Reverse primer RTP_2 5′-CCG-ATC-CCT-AGT-CGG-CAT-AG-3′
Probe 1 RTP_p1 5′-3FL-TTC-AAC-TAC-gAg-CTT-TTT-
AAC-Tg-3′
Probe 2 RTP_p2 5′-LC-Red640-AAC-AAC-TTT-AAT-ATA-
CgC-TAT-Tgg A-3′
Pan-fungal PCR 2 (variable ITS-2 region of the fungal rRNA operon)
Forward primer 5.8S 5′-GTG-AAT-CAT-CGA-RTC-TTT-GAA-C-
3′
Reverse primer 28S1-rev 5′-TAT-GCT-TAA-GTT-CAG-CGG-GTA-3′
Pan-fungal PCR 3 (variable 28S rRNA gene region)
Forward primer 28S-10 5′-GAC-ATG-GGT-TAG-TCG-ATC-CTA-3′
Reverse primer 28S-12-rev 5′-CCT-TAT-CTA-CAT-TRT-TCT-ATC-
AAC-3′
Pan-fungal PCR 4 (variable ITS-2 region of the fungal rRNA operon)
Forward primer ITS-3 5′-GCA-TCG-ATG-AAG-AAC-GCA-GC-3′
Reverse primer ITS-4 5′-TCC-TCC-GCT-TAT-TGA-TAT-GC-3′
Pan fungal PCR 5 (variable ITS-1 region of the fungal rRNA operon)
Forward primer ITS-1 5′-TCC-GTA-GGT-GAA-CCT-GCG-G-3′
Reverse primer ITS-2 5′-GCT-GCG-TTC-TTC-ATC-GAT-GC-3′
Histoplasma capsulatum PCR (gene encoding the unique fungal 100-
kDa-like protein)
Forward primer 1 Hc I 5′-GCG-TTC-CGA-GCC-TTC-CAC-CTC-
AAC-3’
Forward primer 2 Hc III 5′-GAG-ATC-TAG-TCG-CGG-CCA-GGT-
TCA-3’
Reverse primer 1 Hc IV 5′-AGG-AGA-GAA-CTG-TAT-CGG-TGG-
CTT-G-3’
Reverse primer 3 Hc II 5′-ATG-TCC-CAT-CGG-GCG-CCG-TGT-
AGT-3’
Mucorales PCR (18S rRNA gene)
Forward primer ZM1 5′-ATT-ACC-ATG-AGC-AAA-TCA-GA-3’
Reverse primer 1 ZM3 5′-CAA-TCC-AAG-AAT-TTC-ACC-TCT-
AG-3‘
Reverse primer 2 ZM2 5′-TCC-GTC-AAT-TCC-TTT-AAG-TTT-C-
3’
Duplex PCR for Entamoeba histolytica and Entamoeba dispar (fragment
of the ribosomal RNA gene located on an episomal plasmid)
Forward primer Ehd-239F 5′-ATT-GTC-GTG-GCA-TCC-TAA-CTC-A-
3′
Reverse primer Ehd-88R 5′-GCG-GAC-GGC-TCA-TTA-TAA-CA-3′
Probe 1 histolytica-96 T (spe-
cific for E. histolytica)
5′-JOE-TCA-TTG-AAT-GAA-TTG-GCC-
ATT-T-BHQ1–3′




Inhibition control PCR (Phocid herpesvirus 1 (PhHV-1) 1 gB gene)
Forward primer PhHV-267 s 5′-GGG-CGA-ATC-ACA-GAT-TGA-ATC-
3′
Reverse primer PhHV-337as 5′-GCG-GTT-CCA-AAC-GTA-CCA-A-3′
Table 10 PCR Oligonucleotides Used for the Molecular
Characterization of the Samples [7, 13, 62, 63] (Continued)
Probe PhHV-305tq 5′-Cy55-TTT-TTA-TGT-GTC-CGC-CAC-
CAT-CTG-GAT-C-BBQ-3′
Sample quality assessment PCR (human 18S rRNA gene)
Forward primer 18S-f 5′-CTC-TTA-GCT-GAG-TGT-CCC-GC-3′




Table 11 Genera with Potential Etiological Relevance for
Chromoblastomycosis, Mucormycosis, Mycetoma, or
Rhinosporidiosis-like Disease
Chromoblastomycosis-associated pathogens:
Achaetomium spp., Alternaria spp., Aureobasidium spp., Bipolaris spp.,
Botryosphaeria spp., Capronia spp., Chaetomium spp.,
Cladophialophora spp., Cladosporium spp., Cochliobolus spp.,
Curvularia spp., Cyphellophora spp., Davidiella spp., Discosphaerina
spp., Exophiala spp., Exserohilum spp., Fonsecaea spp., Graphium spp.,
Hormonema spp., Hortaea spp., Lasiodiplodia spp., Lewia spp.,
Nattrassia spp., Ochroconis spp., Phaeacremonium spp., Phialemonium
spp., Pleurostomophora spp., Phialophora spp., Pseudallescheria spp.,
Ramichloridium spp., Rhinocladiella spp., Sarcinomyces spp.,
Scedosporium spp., Scytalidium spp., Setosphaeria spp., Sporothrix
spp., and Sydowia spp. [58]
Mucormycosis-associated pathogens:
Absidia spp., Apophysomyces spp., Cokeromyces spp.,
Cunninghamella spp., Mortierella spp., Mucor spp., Rhizomucor spp.,
Rhizopus spp., Saksenaea spp., and Syncephalastrum spp. [59]
Mycetoma-associated pathogens:
Acremonium spp., Aspergillus spp., Fusarium spp., Leptosphaeria spp.,
Madurella spp., Pseudallescheria spp., and Scedosporium spp. The
bacteria-associated actinomycetoma can be caused by species of the
genera Actinomadura spp., Nocardia spp., and Streptomyces spp. [60]
Rhinosporidiosis-like disease-associated pathogens:
Lacazia spp., Pythium spp., and Rhinosporidium spp. [61]
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the Medical Association of Hamburg (document number
WF-028/13) in line with national and ICH-GCP guide-
lines. Consent for the anonymous use of the materials
was not demanded by the ethics committee. In detail,
because the anonymized samples cannot be assigned to
a human being, the project did not constitute a research
project on humans according to the definitions of § 9 (2)
of the Hamburg Medical Association Act for health pro-
fessions and was also not restricted by § 15 (1) of the
Professional Regulations for physicians in Hamburg,
Germany.
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